Literature DB >> 35224498

Discovery of FtsZ inhibitors by virtual screening as antibacterial agents and study of the inhibition mechanism.

Ruo-Lan Du1, Ning Sun1, Yik-Hong Fung1, Yuan-Yuan Zheng1, Yu-Wei Chen1, Pak-Ho Chan1, Wing-Leung Wong1, Kwok-Yin Wong1.   

Abstract

Inhibition of bacterial cell division is a novel mechanistic action in the development of new antimicrobial agents. The FtsZ protein is an important antimicrobial drug target because of its essential role in bacterial cell division. In the present study, potential inhibitors of FtsZ were identified by virtual screening followed by in vivo and in vitro bioassays. One of the candidates, Dacomitinib (S2727), shows for the first time its potent inhibitory activity against the MRSA strains. The binding mode of Dacomitinib in FtsZ was analyzed by docking, and Asp199 and Thr265 are thought to be essential residues involved in the interactions. This journal is © The Royal Society of Chemistry.

Entities:  

Year:  2021        PMID: 35224498      PMCID: PMC8792978          DOI: 10.1039/d1md00249j

Source DB:  PubMed          Journal:  RSC Med Chem        ISSN: 2632-8682


  42 in total

Review 1.  The keepers of the ring: regulators of FtsZ assembly.

Authors:  Cristina Ortiz; Paolo Natale; Laura Cueto; Miguel Vicente
Journal:  FEMS Microbiol Rev       Date:  2015-09-15       Impact factor: 16.408

2.  Structural insights into the conformational variability of FtsZ.

Authors:  María A Oliva; Daniel Trambaiolo; Jan Löwe
Journal:  J Mol Biol       Date:  2007-08-29       Impact factor: 5.469

3.  Identification of a new class of FtsZ inhibitors by structure-based design and in vitro screening.

Authors:  Fung-Yi Chan; Ning Sun; Marco A C Neves; Polo Chun-Hung Lam; Wai-Hong Chung; Lai-King Wong; Ho-Yin Chow; Dik-Lung Ma; Pak-Ho Chan; Yun-Chung Leung; Tak-Hang Chan; Ruben Abagyan; Kwok-Yin Wong
Journal:  J Chem Inf Model       Date:  2013-07-25       Impact factor: 4.956

4.  An inhibitor of FtsZ with potent and selective anti-staphylococcal activity.

Authors:  David J Haydon; Neil R Stokes; Rebecca Ure; Greta Galbraith; James M Bennett; David R Brown; Patrick J Baker; Vladimir V Barynin; David W Rice; Sveta E Sedelnikova; Jonathan R Heal; Joseph M Sheridan; Sachin T Aiwale; Pramod K Chauhan; Anil Srivastava; Amit Taneja; Ian Collins; Jeff Errington; Lloyd G Czaplewski
Journal:  Science       Date:  2008-09-19       Impact factor: 47.728

Review 5.  Therapeutic potential of FtsZ inhibition: a patent perspective.

Authors:  Divya Awasthi; Kunal Kumar; Iwao Ojima
Journal:  Expert Opin Ther Pat       Date:  2011-03-18       Impact factor: 6.674

6.  Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against Aspergillus fumigatus.

Authors:  Joseph Meletiadis; Spyros Pournaras; Emmanuel Roilides; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2009-12-07       Impact factor: 5.191

7.  Antibacterial activity of alpha-mangostin against vancomycin resistant Enterococci (VRE) and synergism with antibiotics.

Authors:  Y Sakagami; M Iinuma; K G N P Piyasena; H R W Dharmaratne
Journal:  Phytomedicine       Date:  2005-03       Impact factor: 5.340

Review 8.  Assembly and activation of the Escherichia coli divisome.

Authors:  Shishen Du; Joe Lutkenhaus
Journal:  Mol Microbiol       Date:  2017-05-25       Impact factor: 3.501

9.  Inhibition of bacterial cell division protein FtsZ by cinnamaldehyde.

Authors:  Prerna Domadia; Sanjay Swarup; Anirban Bhunia; J Sivaraman; Debjani Dasgupta
Journal:  Biochem Pharmacol       Date:  2007-06-23       Impact factor: 5.858

10.  Comparison of small molecule inhibitors of the bacterial cell division protein FtsZ and identification of a reliable cross-species inhibitor.

Authors:  David E Anderson; Michelle B Kim; Jared T Moore; Terrence E O'Brien; Nohemy A Sorto; Charles I Grove; Laura L Lackner; James B Ames; Jared T Shaw
Journal:  ACS Chem Biol       Date:  2012-10-05       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.